Stefan Jaroch / Weinmann Hilmar (eds.)

Chemical Genomics

Small Molecule Probes to Study Cellular Function
Herausgegeben:Jaroch, Stefan; Weinmann, Hilmar

• Gebundenes Buch

Produktbeschreibung

Chemical genomics is a highly interdisciplinary and very exciting field of research both in academics and in the life sciences industry. The Ernst Schering Research Foundation Workshop 58 was organized to bring together scientific leaders in the field to discuss the implications of chemical genomics for drug discovery. Various aspects of the interface between chemistry and biology are covered in this volume, such as chemogenomics efforts in the pharmaceutical industry, diversity-oriented synthesis, chemogenomic approaches to the study of cell function, screening technologies, and natural products as tools in chemical biology.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Ernst Schering Foundation Symposium Proceedings 58
• Verlag: Springer / Springer Berlin Heidelberg / Springer, Berlin
• Artikelnr. des Verlages: 11524632
• 2006
• Seitenzahl: 196
• Erscheinungstermin: 19. April 2006
• Englisch
• Abmessung: 216mm x 153mm x 16mm
• Gewicht: 384g
• ISBN-13: 9783540278658
• ISBN-10: 3540278656
• Artikelnr.: 14998934

Autorenporträt

Hilmar Weinmann studied Chemistry at the universities of Tübingen and Hannover (Germany). He joined Schering in 1995, where he is currently a department head of Medicinal Chemistry. His main fields of expertise are in oncology, dermatology and gender healthcare.

Inhaltsangabe

Chemogenomics in Drug Discovery.- Chemogenomics Strategies for GPCR Hit Finding.- Chemogenomics Approaches to GPCR Lead Finding.- Diversity-Oriented Synthesis: A Challenge for Synthetic Chemists.- Probing Protein Function with Small Molecules.- Tamoxifen-Based Probes for the Study of Estrogen Receptor-Mediated Transcription.- Protein Structure Similarity Clustering (PSSC) and Natural Product Structure as Guiding Principles for Chemical Genomics.- Novel Strategies in Drug Discovery: Current Challenges in Biomolecular Screening.